Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Clinical Information System01:27

Nursing Clinical Information System

956
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
956
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

974
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
974
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccine-Preventable Disease Control in the WHO African Region After the COVID-19 Public Health Emergency of International Concern: Implications for Recovery, Resilience, and System Transformation.

Vaccines·2026
Same author

Impact of Rotavirus Vaccine on Rotavirus Diarrhea-Associated Hospitalizations among Children under 5 Years of Age in Uganda.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap.

The Lancet. Infectious diseases·2026
Same author

The AFRO-MoVE network: COVID-19 vaccine research in Africa.

Vaccine·2026
Same author

Country-level perspectives and priorities to guide the development of Invasive non-Typhoidal Salmonella (iNTS) vaccines: Insights from seven countries.

PLoS neglected tropical diseases·2026
Same author

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Vaccine·2026
Same journal

Development and Validation of a Brief Healthcare Insecurity Scale in a Sample of U.S. Adults Living with and without HIV.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Physician-led Switching from Reference Biologics to Biosimilars: What is the Effect on selected Health-Related Outcomes and Costs for IBD Patients in Germany?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Critical Comments by the European Medicines Agency on Patient-Reported Outcomes in Regulatory Submissions (2020-2023).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Development, use and psychometric properties of vision and hearing bolt-ons for EQ-5D-3L and EQ-5D-5L: a systematic review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
See all related articles

Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.0K

The CAPACITI Decision-Support Tool for National Immunization Programs.

Siobhan Botwright1, Birgitte K Giersing1, Martin I Meltzer2

  • 1World Health Organization, Geneva, Switzerland.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|August 10, 2021
PubMed
Summary
This summary is machine-generated.

National immunization programs in low- and middle-income countries (LMICs) can use the CAPACITI decision-support tool to prioritize vaccines. This evidence-based tool incorporates multiple criteria and stakeholder views for context-specific decision-making.

Keywords:
HTALMICMCDAdecision-supportimmunizationpriority settingvaccine

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.5K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.2K

Related Experiment Videos

Last Updated: Oct 25, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.0K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.5K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.2K

Area of Science:

  • Global Health
  • Health Policy
  • Decision Science

Background:

  • Low- and middle-income countries (LMICs) face increasing vaccine recommendations and domestic funding responsibilities.
  • National immunization programs require tools to adapt global guidance to local contexts.
  • Prioritizing vaccines is crucial for effective public health strategies in resource-limited settings.

Purpose of the Study:

  • To introduce the CAPACITI decision-support tool, designed for national immunization programs in LMICs.
  • To provide a structured, evidence-based process for prioritizing or selecting among multiple vaccination options.
  • To facilitate context-specific decision-making in immunization program planning.

Main Methods:

  • The CAPACITI tool employs multi-criteria decision analysis (MCDA) to integrate diverse evidence and stakeholder perspectives.
  • Developed iteratively with 12 countries across Africa, Asia, and the Americas.
  • Structured into five sections: decision question, criteria, evidence assessment, appraisal, and recommendation.

Main Results:

  • The Excel-based tool guides users through a transparent process, emphasizing stakeholder engagement and country ownership.
  • It accommodates various MCDA approaches, including hybrid models, and integrates flexibly with existing country processes.
  • Pilot countries recognized its value in evaluating trade-offs and the impact of data quality.

Conclusions:

  • The CAPACITI tool supports evidence-based, context-specific decision-making for vaccine prioritization in LMICs.
  • It empowers national immunization programs to tailor global recommendations to their unique settings.
  • Iterative use and adaptation are expected to streamline decision-making processes and enhance country ownership.